Allovir, Inc. (KLRS) SEC Filings — 2024
21 SEC filings for Allovir, Inc. (KLRS) in 2024.
Filings
- Allovir Appoints New Chief Medical Officer — 8-K · Dec 20, 2024
- Allovir Files 2025 Proxy Statement — DEF 14A · Dec 6, 2024
- Allovir, Inc. Files Q3 2024 10-Q — 10-Q · Nov 12, 2024
- Allovir, Inc. Files 8-K with Material Agreement — 8-K · Nov 8, 2024
- Allovir, Inc. SC 13G Filing — SC 13G · Oct 11, 2024
- Allovir, Inc. Files Q2 2024 10-Q — 10-Q · Aug 9, 2024
- Allovir, Inc. SC 13G/A Filing — SC 13G/A · Aug 2, 2024
- Allovir, Inc. Terminates Material Definitive Agreement — 8-K · Jul 2, 2024
- Allovir Terminates Material Definitive Agreement — 8-K · Jun 11, 2024
- Allovir, Inc. Files 8-K on Security Holder Vote Matters — 8-K · Jun 7, 2024
- Allovir Appoints New Directors, CMO Departs — 8-K · Jun 3, 2024
- Allovir, Inc. Files 10-Q for Period Ending March 31, 2024 — 10-Q · May 13, 2024
- AlloVir, Inc. Announces 2024 Annual Meeting of Stockholders — DEF 14A · Apr 23, 2024
- Allovir, Inc. Files 2023 Annual Report on Form 10-K — 10-K · Mar 15, 2024
- Allovir, Inc. SC 13G/A Filing — SC 13G/A · Feb 13, 2024
- Allovir (ALVR) Receives Nasdaq Delisting Notice for Low Bid Price — 8-K · Feb 12, 2024
- Artal International Amends AlloVir Stake as of Dec 31, 2023 — SC 13G/A · Feb 9, 2024
- FMR LLC Cuts Allovir Stake to 4.99%; Holds 5.69M Shares — SC 13G/A · Feb 9, 2024
- EcoR1 Capital Takes 10.0% Stake in Allovir (ALVR) — SC 13G · Feb 1, 2024
- John R. Wilson Maintains 3.16M Share Stake in Allovir (ALVR) — SC 13G/A · Jan 9, 2024
- Allovir Reports Costs from Exit/Disposal Activities on Jan 1 — 8-K · Jan 4, 2024